BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. World J Psychiatr 2016; 6(1): 102-117 [PMID: 27014601 DOI: 10.5498/wjp.v6.i1.102] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 76] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Fallah H, Azari I, Neishabouri SM, Oskooei VK, Taheri M, Ghafouri-Fard S. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia. Sci Rep 2019;9:12737. [PMID: 31484957 DOI: 10.1038/s41598-019-49265-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
2 Kazakos CT, Karageorgiou V. Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant Data. Schizophr Bull 2020;46:27-42. [PMID: 31626695 DOI: 10.1093/schbul/sbz106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Davison J, O'Gorman A, Brennan L, Cotter DR. A systematic review of metabolite biomarkers of schizophrenia. Schizophr Res 2018;195:32-50. [PMID: 28947341 DOI: 10.1016/j.schres.2017.09.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
4 Li Z, Li X, Jin M, Liu Y, He Y, Jia N, Cui X, Liu Y, Hu G, Yu Q. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis. J Psychiatr Res 2022;147:39-49. [PMID: 35016150 DOI: 10.1016/j.jpsychires.2022.01.003] [Reference Citation Analysis]
5 Kim E, Li J, Kang M, Kelly DL, Chen S, Napolitano A, Panzella L, Shi X, Yan K, Wu S, Shen J, Bentley WE, Payne GF. Redox Is a Global Biodevice Information Processing Modality. Proc IEEE Inst Electr Electron Eng 2019;107:1402-24. [PMID: 32095023 DOI: 10.1109/JPROC.2019.2908582] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 6.3] [Reference Citation Analysis]
6 Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Karakuła KH, Zalewska A, Maciejczyk M, Karakula-Juchnowicz H. Pro/Antioxidant State as a Potential Biomarker of Schizophrenia. J Clin Med 2021;10:4156. [PMID: 34575267 DOI: 10.3390/jcm10184156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li C, Shi Z, Ji J, Niu G, Liu Z. Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study. Neuropsychiatr Dis Treat 2021;17:2575-85. [PMID: 34408419 DOI: 10.2147/NDT.S322005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Rodríguez B, Nani JV, Almeida PGC, Brietzke E, Lee RS, Hayashi MAF. Neuropeptides and oligopeptidases in schizophrenia. Neurosci Biobehav Rev 2020;108:679-93. [PMID: 31794779 DOI: 10.1016/j.neubiorev.2019.11.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
9 Ershova ES, Jestkova EM, Chestkov IV, Porokhovnik LN, Izevskaya VL, Kutsev SI, Veiko NN, Shmarina G, Dolgikh O, Kostyuk SV. Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patients. J Psychiatr Res 2017;87:15-22. [PMID: 27987480 DOI: 10.1016/j.jpsychires.2016.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
10 Huang X, Huang X, Zhou Y, He H, Mei F, Sun B, Soares JC, Yang Zhang X. Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population. Psychiatry Res 2017;257:279-83. [PMID: 28783576 DOI: 10.1016/j.psychres.2017.07.076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
11 Ordak M, Libman-Sokolowska M, Nasierowski T, Badyra B, Kaczmarek L, Muszynska E, Bujalska-Zadrozny M. Matrix metalloproteinase-3 serum levels in schizophrenic patients. Int J Psychiatry Clin Pract 2022;:1-7. [PMID: 35357267 DOI: 10.1080/13651501.2022.2057332] [Reference Citation Analysis]
12 Eising E, Pelzer N, Vijfhuizen LS, Vries B, Ferrari MD, 't Hoen PA, Terwindt GM, van den Maagdenberg AM. Identifying a gene expression signature of cluster headache in blood. Sci Rep 2017;7:40218. [PMID: 28074859 DOI: 10.1038/srep40218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
13 Matsumoto M, Walton NM, Yamada H, Kondo Y, Marek GJ, Tajinda K. The impact of genetics on future drug discovery in schizophrenia. Expert Opin Drug Discov 2017;12:673-86. [PMID: 28521526 DOI: 10.1080/17460441.2017.1324419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y. Serum BICC1 levels are significantly different in various mood disorders. Neuropsychiatr Dis Treat 2019;15:259-65. [PMID: 30697050 DOI: 10.2147/NDT.S190048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Ramos Ferreira S, Moura D, Oliveira P, Santos V, Bajouco M, Morais S, Coroa M, Manadas B, Madeira N. Metabolic parameters as possible diagnostic predictors in first-episode psychosis: An exploratory retrospective cohort study. Early Interv Psychiatry 2021. [PMID: 34808705 DOI: 10.1111/eip.13257] [Reference Citation Analysis]
16 Konkova MS, Ershova ES, Savinova EA, Malinovskaya EM, Shmarina GV, Martynov AV, Veiko RV, Zakharova NV, Umriukhin P, Kostyuk GP, Izhevskaya VL, Kutsev SI, Veiko NN, Kostyuk SV. 1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia. Front Cell Dev Biol 2020;8:386. [PMID: 32714923 DOI: 10.3389/fcell.2020.00386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Solberg DK, Refsum H, Andreassen OA, Bentsen H. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatr 2019;31:202-12. [PMID: 31178002 DOI: 10.1017/neu.2019.14] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
18 Taraskina AE, Nasyrova RF, Zabotina AM, Sosin DN, Sosina КА, Ershov EE, Grunina MN, Krupitsky EM. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines. BMC Psychiatry 2017;17:394. [PMID: 29221470 DOI: 10.1186/s12888-017-1562-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pollak TA, Rogers JP, Nagele RG, Peakman M, Stone JM, David AS, McGuire P. Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. Schizophr Bull 2019;45:233-46. [PMID: 29474698 DOI: 10.1093/schbul/sby021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Liu S, Zhang F, Shugart YY, Yang L, Li X, Liu Z, Sun N, Yang C, Guo X, Shi J, Wang L, Cheng L, Zhang K, Yang T, Xu Y. The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring. Transl Psychiatry 2017;7:e998. [PMID: 28072411 DOI: 10.1038/tp.2016.268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
21 Mohite S, Yang F, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Sharma AN, Fries GR, Walss-Bass C, Soares JC, Okusaga OO. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls. PLoS One 2017;12:e0174073. [PMID: 28334045 DOI: 10.1371/journal.pone.0174073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
22 Lee CH, Sinclair D, O'donnell M, Galletly C, Liu D, Weickert CS, Weickert TW. Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research 2019;213:87-95. [DOI: 10.1016/j.schres.2019.06.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Kim H, Wang X, Jin P. Developing DNA methylation-based diagnostic biomarkers. J Genet Genomics. 2018;45:87-97. [PMID: 29496486 DOI: 10.1016/j.jgg.2018.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
24 Liu S, Zhang F, Wang X, Shugart YY, Zhao Y, Li X, Liu Z, Sun N, Yang C, Zhang K, Yue W, Yu X, Xu Y. Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validation. Sci Rep 2017;7. [DOI: 10.1038/s41598-017-15751-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
25 Peitl V, Getaldić-Švarc B, Karlović D. Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in Depression. Psychiatry Investig 2020;17:579-86. [PMID: 32492767 DOI: 10.30773/pi.2020.0033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Fountoulakis KN, Panagiotidis P, Tegos T, Kimiskidis V, Nimatoudis I. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34842982 DOI: 10.1007/s00406-021-01357-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Schmitt A, Martins-de-souza D, Akbarian S, Cassoli JS, Ehrenreich H, Fischer A, Fonteh A, Gattaz WF, Gawlik M, Gerlach M, Grünblatt E, Halene T, Hasan A, Hashimoto K, Kim Y, Kirchner S, Kornhuber J, Kraus TF, Malchow B, Nascimento JM, Rossner M, Schwarz M, Steiner J, Talib L, Thibaut F, Riederer P, Falkai P; The Members of the WFSBP Task Force on Biological Markers. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry 2017;18:330-56. [DOI: 10.1080/15622975.2016.1224929] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
28 Ruiz-Sánchez E, Jiménez-Genchi J, Alcántara-Flores YM, Castañeda-González CJ, Aviña-Cervantes CL, Yescas P, Del Socorro González-Valadez M, Martínez-Rodríguez N, Ríos-Ortiz A, González-González M, López-Navarro ME, Rojas P. Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study. BMC Psychiatry 2021;21:86. [PMID: 33563249 DOI: 10.1186/s12888-021-03081-w] [Reference Citation Analysis]
29 Sewell MDE, Jiménez-Sánchez L, Shen X, Edmondson-Stait AJ, Green C, Adams MJ, Rifai OM, McIntosh AM, Lyall DM, Whalley HC, Lawrie SM. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank. Brain Behav Immun 2021:S0889-1591(21)00233-6. [PMID: 34107350 DOI: 10.1016/j.bbi.2021.06.002] [Reference Citation Analysis]
30 Gilabert-Juan J, López-Campos G, Sebastiá-Ortega N, Guara-Ciurana S, Ruso-Julve F, Prieto C, Crespo-Facorro B, Sanjuán J, Moltó MD. Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain Behav Immun 2019;80:909-15. [PMID: 31078689 DOI: 10.1016/j.bbi.2019.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Yakimets AV, Zozulya SA, Oleichik IV, Klyushnik TP. [Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2018;118:70-6. [PMID: 29652309 DOI: 10.17116/jnevro20181183170-76] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Reay WR, Kiltschewskij DJ, Geaghan MP, Atkins JR, Carr VJ, Green MJ, Cairns MJ. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders. Sci Adv 2022;8:eabj8969. [PMID: 35385317 DOI: 10.1126/sciadv.abj8969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
33 Perkovic MN, Erjavec GN, Strac DS, Uzun S, Kozumplik O, Pivac N. Theranostic Biomarkers for Schizophrenia. Int J Mol Sci 2017;18:E733. [PMID: 28358316 DOI: 10.3390/ijms18040733] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 8.6] [Reference Citation Analysis]
34 Jiang H, Chen S, Li C, Lu N, Yue Y, Yin Y, Zhang Y, Zhi X, Zhang D, Yuan Y. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment. Transl Psychiatry 2017;7:e1079. [PMID: 28375203 DOI: 10.1038/tp.2017.43] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
35 Mansfield JR, Guest PC, Burks J. Phenotyping Multiple Subsets of Immune Cells In Situ in Formalin-Fixed, Paraffin-Embedded Tissue Sections. Adv Exp Med Biol 2017;974:327-38. [PMID: 28353253 DOI: 10.1007/978-3-319-52479-5_32] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Jonak K, Syta A, Karakuła-Juchnowicz H, Krukow P. The Clinical Application of EEG-Signals Recurrence Analysis as a Measure of Functional Connectivity: Comparative Case Study of Patients with Various Neuropsychiatric Disorders. Brain Sci 2020;10:E380. [PMID: 32560205 DOI: 10.3390/brainsci10060380] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Rodrigues-Amorim D, Rivera-Baltanás T, López M, Spuch C, Olivares JM, Agís-Balboa RC. Schizophrenia: A review of potential biomarkers. J Psychiatr Res 2017;93:37-49. [PMID: 28578207 DOI: 10.1016/j.jpsychires.2017.05.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
38 Ľupták M, Michaličková D, Fišar Z, Kitzlerová E, Hroudová J. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World J Psychiatr 2021; 11(7): 277-296 [PMID: 34327122 DOI: 10.5498/wjp.v11.i7.277] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kim S, Jo Y, Webster MJ, Lee D. Shared co-expression networks in frontal cortex of the normal aged brain and schizophrenia. Schizophr Res 2019;204:253-61. [PMID: 30224231 DOI: 10.1016/j.schres.2018.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. D-Amino Acids as a Biomarker in Schizophrenia. Diseases 2022;10:9. [DOI: 10.3390/diseases10010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jia J, Liu X, Ma L, Xu Y, Ren Y. A preliminary analysis of LncRNA biomarkers for schizophrenia. Epigenomics 2021;13:1443-58. [PMID: 34528440 DOI: 10.2217/epi-2021-0223] [Reference Citation Analysis]
42 Zhuo C, Li G, Lin X, Jiang D, Xu Y, Tian H, Wang W, Song X. Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review. Brain Imaging Behav 2021;15:1115-33. [PMID: 32304018 DOI: 10.1007/s11682-020-00284-9] [Reference Citation Analysis]
43 Arsalidou M, Yaple Z, Jurcik T, Ushakov V. Cognitive Brain Signatures of Youth With Early Onset and Relatives With Schizophrenia: Evidence From fMRI Meta-analyses. Schizophr Bull 2020;46:857-68. [PMID: 31978222 DOI: 10.1093/schbul/sbz130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Kajitani K, Yanagimoto K, Nakabeppu Y. Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. Psychopharmacology (Berl) 2017;234:2919-27. [PMID: 28698921 DOI: 10.1007/s00213-017-4683-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
45 Sabaie H, Moghaddam MM, Moghaddam MM, Ahangar NK, Asadi MR, Hussen BM, Taheri M, Rezazadeh M. Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia. Sci Rep 2021;11:24413. [PMID: 34952924 DOI: 10.1038/s41598-021-03993-3] [Reference Citation Analysis]
46 Engelke R, Ouanes S, Ghuloum S, Chamali R, Kiwan N, Sarwath H, Schmidt F, Suhre K, Al-Amin H. Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls. Front Psychiatry 2022;13:809071. [PMID: 35546954 DOI: 10.3389/fpsyt.2022.809071] [Reference Citation Analysis]
47 Makinodan M, Iwata K, Ikawa D, Yamashita Y, Yamamuro K, Toritsuka M, Kimoto S, Okumura K, Yamauchi T, Yoshino H, Tsujii M, Sugiyama T, Tsuchiya K, Mori N, Matsuzaki H, Kishimoto T. Tumor necrosis factor-alpha expression in peripheral blood mononuclear cells correlates with early childhood social interaction in autism spectrum disorder. Neurochem Int 2017;104:1-5. [PMID: 28007470 DOI: 10.1016/j.neuint.2016.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
48 Liu J, Chen J, Perrone-Bizzozero N, Calhoun VD. A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia. Front Genet 2018;9:343. [PMID: 30190726 DOI: 10.3389/fgene.2018.00343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Levchenko A, Nurgaliev T, Kanapin A, Samsonova A, Gainetdinov RR. Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders. Heliyon 2020;6:e03990. [PMID: 32462093 DOI: 10.1016/j.heliyon.2020.e03990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Yin J, Lu Y, Yu S, Dai Z, Zhang F, Yuan J. Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment. Hereditas 2020;157:43. [PMID: 33158463 DOI: 10.1186/s41065-020-00158-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Zhuo C, Yao Y, Xu Y, Liu C, Chen M, Ji F, Li J, Tian H, Jiang D, Lin C, Chen C. Schizophrenia and gut-flora related epigenetic factors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;90:49-54. [DOI: 10.1016/j.pnpbp.2018.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
52 Cao T, Li N, Cai H. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist? Schizophr Res 2020;226:95-110. [PMID: 30935700 DOI: 10.1016/j.schres.2019.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
53 Chaumette B, Kebir O, Pouch J, Ducos B, Selimi F, Gaillard R, Krebs MO; ICAAR study group. Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis. Schizophr Bull 2019;45:247-55. [PMID: 29471546 DOI: 10.1093/schbul/sby009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li Z, He Y, Han H, Zhou Y, Ma X, Wang D, Zhou J, Ren H, Yuan L, Tang J, Zong X, Hu M, Chen X. COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes. Front Psychiatry 2018;9:577. [PMID: 30483162 DOI: 10.3389/fpsyt.2018.00577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Healy-Stoffel M, Levant B. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. CNS Neurol Disord Drug Targets 2018;17:216-32. [PMID: 29651972 DOI: 10.2174/1871527317666180412153612] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 13.7] [Reference Citation Analysis]
56 Granger KT, Talwar A, Barnett JH. Latent inhibition and its potential as a biomarker for schizophrenia. Biomarkers in Neuropsychiatry 2020;3:100025. [DOI: 10.1016/j.bionps.2020.100025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Lee D, Seo J, Jeong HC, Lee H, Lee SB. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons. Front Mol Neurosci 2021;14:756613. [PMID: 34867186 DOI: 10.3389/fnmol.2021.756613] [Reference Citation Analysis]
58 Ershova ES, Agafonova ON, Zakharova NV, Bravve LV, Jestkova EM, Golimbet VE, Lezheiko TV, Morozova AY, Martynov AV, Veiko RV, Umriukhin PE, Kostyuk GP, Kutsev SI, Veiko NN, Kostyuk SV. Copy Number Variation of Satellite III (1q12) in Patients With Schizophrenia. Front Genet 2019;10:1132. [PMID: 31850056 DOI: 10.3389/fgene.2019.01132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tani E, Ohnuma T, Hirose H, Nakayama K, Mao W, Nakadaira M, Orimo N, Yamashita H, Takebayashi Y, Miki Y, Katsuta N, Nishimon S, Hasegawa T, Komiyama E, Suga Y, Ikeda S, Arai H. Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia. Int J Methods Psychiatr Res 2019;28:e1769. [PMID: 30701623 DOI: 10.1002/mpr.1769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Goossens J, Morrens M, Coppens V. The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review. Mol Diagn Ther 2021;25:283-99. [PMID: 33978935 DOI: 10.1007/s40291-021-00516-8] [Reference Citation Analysis]
61 Dondé C, Mondino M, Brunelin J, Haesebaert F. Sensory-targeted cognitive training for schizophrenia. Expert Rev Neurother 2019;19:211-25. [PMID: 30741038 DOI: 10.1080/14737175.2019.1581609] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Kim E, Keskey Z, Kang M, Kitchen C, Bentley WE, Chen S, Kelly DL, Payne GF. Validation of oxidative stress assay for schizophrenia. Schizophrenia Research 2019;212:126-33. [DOI: 10.1016/j.schres.2019.07.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
63 Rahmani E, Schweiger R, Shenhav L, Wingert T, Hofer I, Gabel E, Eskin E, Halperin E. BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation reference. Genome Biol 2018;19:141. [PMID: 30241486 DOI: 10.1186/s13059-018-1513-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
64 Tang X, Zhou C, Gao J, Duan W, Yu M, Xiao W, Zhang X, Dong H, Wang X, Zhang X. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. BMC Psychiatry 2019;19:254. [PMID: 31420036 DOI: 10.1186/s12888-019-2231-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Pinto JV, Passos IC, Gomes F, Reckziegel R, Kapczinski F, Mwangi B, Kauer-Sant'Anna M. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach. Schizophr Res 2017;188:182-4. [PMID: 28110815 DOI: 10.1016/j.schres.2017.01.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
66 Kriisa K, Leppik L, Balõtšev R, Ottas A, Soomets U, Koido K, Volke V, Innos J, Haring L, Vasar E, Zilmer M. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment. J Proteome Res 2017;16:3558-66. [PMID: 28786289 DOI: 10.1021/acs.jproteome.7b00279] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
67 Chestkov IV, Jestkova EM, Ershova ES, Golimbet VG, Lezheiko TV, Kolesina NY, Dolgikh OA, Izhevskaya VL, Kostyuk GP, Kutsev SI, Veiko NN, Kostyuk SV. ROS-Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic Patients. Oxid Med Cell Longev 2018;2018:8587475. [PMID: 29682166 DOI: 10.1155/2018/8587475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
68 Loureiro C, Shuhama R, Fachim H, Menezes P, Del-ben C, Louzada-junior P. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis. Schizophrenia Research 2018;202:55-63. [DOI: 10.1016/j.schres.2018.06.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
69 Ma J, Yan L, Guo T, Yang S, Ni D, Liu Y, Wang J. A pilot study of biomarkers of oxidative stress in serum and schizophrenia. Psychiatry Res 2020;284:112757. [PMID: 31955055 DOI: 10.1016/j.psychres.2020.112757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
70 Grunina MN, Belinskaia MA, Zhuravlev AS, Nasyrova RF, Krupitsky EM, Taraskina AE, Zabotina AM. Aberrant alternative splicing of HTR2A exon II in peripheral blood lymphocytes of drug-naïve schizophrenic patients. Heliyon 2020;6:e05809. [PMID: 33409390 DOI: 10.1016/j.heliyon.2020.e05809] [Reference Citation Analysis]
71 Lu Z, Wen T, Wang Y, Kan W, Xun G. Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study. BMC Psychiatry 2020;20:241. [PMID: 32414343 DOI: 10.1186/s12888-020-02635-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Chen S, Jiang H, Liu Y, Hou Z, Yue Y, Zhang Y, Zhao F, Xu Z, Li Y, Mou X, Li L, Wang T, Zhao J, Han C, Sui Y, Wang M, Yang Z, Lu Y, Zhu Y, Li J, Shen X, Sun F, Chen Q, Chen H, Yuan Y. Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders. Sci Rep 2017;7:6871. [PMID: 28761093 DOI: 10.1038/s41598-017-06832-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
73 Kim E, Zhao Z, Rzasa JR, Glassman M, Bentley WE, Chen S, Kelly DL, Payne GF. Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis. Redox Biol 2021;47:102138. [PMID: 34555595 DOI: 10.1016/j.redox.2021.102138] [Reference Citation Analysis]
74 Yahata N, Kasai K, Kawato M. Computational neuroscience approach to biomarkers and treatments for mental disorders: Computational psychiatry. Psychiatry Clin Neurosci 2017;71:215-37. [DOI: 10.1111/pcn.12502] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 10.6] [Reference Citation Analysis]
75 Safari MR, Komaki A, Arsang-jang S, Taheri M, Ghafouri-fard S. Expression Pattern of Long Non-coding RNAs in Schizophrenic Patients. Cell Mol Neurobiol 2019;39:211-21. [DOI: 10.1007/s10571-018-0640-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
76 Ye F, Zhan Q, Xiao W, Sha W, Zhang X. Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia. Int J Methods Psychiatr Res 2018;27:e1727. [PMID: 29901253 DOI: 10.1002/mpr.1727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]